2010 Antibody Biology and Engineering Gordon Research Conference

2010年抗体生物学与工程戈登研究会议

• 批准号: 7796947
• 负责人: ELIZABETH SALLY WARD
• 金额: $ 0.3万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-02-01 至 2011-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7796947
• 关键词: Academia; Antibodies; Area; Autoimmunity; B-Lymphocytes; Biology; Cellular biology; Collaborations; Communicable Diseases; Complement; Development; Engineering; Fostering; Goals; Health; Human; Industry; Lead; Malignant Neoplasms; Process; Request for Proposals; Research; Scanning; Scientist; Text; Therapeutic; Therapeutic antibodies; abstracting; antibody engineering; base; improved; meetings; novel; posters; programs; symposium

DESCRIPTION (provided by applicant): NOTICE: THIS ABSTRACT WAS EXTRACTED FROM APPLICATION AND HAS NOT BEEN PROOFED BY AN SRA.WHEN THERE ARE PROBLEMS WITH THE APPLICATION SCANNING PROCESS, THE EXTRACTED TEXT MAY BE INCORRECT OR INCOMPLETE. ================== This proposal requests partial support for a new Gordon Research Conference (GRC) on 'Antibody Biology and Engineering' to be held in Ventura, CA from March 7th-12th, 2010. The broad and long term goal of the meeting is to bring together scientists from both basic B cell biology and antibody engineering to lead to the development of novel and improved antibody-based therapeutics. Our Specific aims are: 1) To develop an interdisciplinary program which will cover areas ranging from mechanistic studies of B cell tolerance to the successful application of antibody therapeutics; 2) To initiate cross- talk and collaborations amongst scientists in different areas of B cell biology and antibody engineering; 3) To provide a forum for open discussion on the current compelling questions in the areas of B cell biology and antibody engineering that will inspire new directions and developments. Towards these aims, we will convene about 40 speakers and discussion leaders who are either recognized experts or more junior 'up-and-coming stars' in their field together with about 130 attendees. Sessions will be organized into topics which will be complemented by four poster sessions in which all attendees will be encouraged to participate. In addition to provoking discussion about multiple facets of antibody biology and engineering, we anticipate that this new conference will develop into an established forum for fostering interdisciplinary interactions between academia and the biopharma industry. The rapidly expanding use of antibodies as therapeutics in cancer, autoimmunity and infectious disease indicates that this conference will have direct relevance to human health. Antibodies represent a rapidly expanding class of therapeutics to treat cancer, autoimmunity, infectious diseases and other illnesses. The Gordon Research Conference on Antibody Biology and Engineering will cover topics that range from basic aspects of B cell biology to the application of therapeutic antibodies. As such, the conference should foster the development of improved and/or novel antibody-based therapeutics.

描述(由申请人提供)： 注意：此摘要摘自应用程序，未经SRA校对。如果应用程序扫描过程有问题，提取的文本可能不正确或不完整。 = 该提案要求部分支持将于2010年3月7日至12日在加利福尼亚州文图拉举行的新的戈登研究会议(GRC)，主题为‘抗体生物学和工程学’。会议的广泛和长期目标是将基础B细胞生物学和抗体工程的科学家聚集在一起，以开发新的和改进的基于抗体的疗法。我们的具体目标是：1)开发一个跨学科计划，涵盖从B细胞耐受性的机制研究到抗体疗法的成功应用等领域；2)启动B细胞生物学和抗体工程不同领域的科学家之间的相互对话和合作；3)提供一个论坛，就当前B细胞生物学和抗体工程领域的引人注目的问题进行公开讨论，这些问题将启发新的方向和发展。为了达到这些目标，我们将召集约40名演讲者和讨论负责人，他们要么是公认的专家，要么是各自领域更初级的“后起之秀”，以及大约130名与会者。会议将被组织成主题，并将由四个海报会议补充，鼓励所有与会者参加。除了引发关于抗体生物学和工程的多个方面的讨论外，我们预计这次新的会议将发展成为一个促进学术界和生物制药行业之间跨学科互动的既定论坛。抗体作为癌症、自身免疫和传染病治疗药物的使用迅速扩大，这表明这次会议将与人类健康直接相关。抗体代表着一种迅速扩大的治疗癌症、自身免疫、传染病和其他疾病的疗法类别。戈登抗体生物学和工程学研究会议将涵盖从B细胞生物学的基本方面到治疗性抗体的应用的各种主题。因此，大会应该促进改进的和/或新的基于抗体的疗法的发展。